56 related articles for article (PubMed ID: 29927717)
1. Drug Targeting and Biomarkers in Head and Neck Cancers: Insights from Systems Biology Analyses.
Islam T; Rahman R; Gov E; Turanli B; Gulfidan G; Haque A; Arga KY; Haque Mollah N
OMICS; 2018 Jun; 22(6):422-436. PubMed ID: 29927717
[TBL] [Abstract][Full Text] [Related]
2. Identifying Biomarkers and Therapeutic Targets by Multiomic Analysis for HNSCC: Precision Medicine and Healthcare Management.
Kunhabdulla H; Manas R; Shettihalli AK; Reddy CRM; Mustak MS; Jetti R; Abdulla R; Sirigiri DR; Ramdan D; Ammarullah MI
ACS Omega; 2024 Mar; 9(11):12602-12610. PubMed ID: 38524437
[No Abstract] [Full Text] [Related]
3. Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.
Yuan J; Fu Y; Liu Y
Medicine (Baltimore); 2023 Dec; 102(50):e36696. PubMed ID: 38115252
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and immune correlation analysis of mitochondrial autophagy and aging-related genes in lung adenocarcinoma.
Meng X; Song W; Zhou B; Liang M; Gao Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16311-16335. PubMed ID: 37698683
[TBL] [Abstract][Full Text] [Related]
5. Identification of a two metastasis-related prognostic signature in the process of predicting the survival of laryngeal squamous cell carcinoma.
Zheng Y; Wu J; Yan B; Yang Y; Zhong H; Yi W; Cao C; Wang Q
Sci Rep; 2023 Aug; 13(1):13513. PubMed ID: 37598251
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents.
Horaira MA; Islam MA; Kibria MK; Alam MJ; Kabir SR; Mollah MNH
BMC Med Genomics; 2023 Mar; 16(1):64. PubMed ID: 36991484
[TBL] [Abstract][Full Text] [Related]
7. Immune Cells in Head-and-Neck Tumor Microenvironments.
Jumaniyazova E; Lokhonina A; Dzhalilova D; Kosyreva A; Fatkhudinov T
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143308
[TBL] [Abstract][Full Text] [Related]
8. Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing.
Mosharaf MP; Kibria MK; Hossen MB; Islam MA; Reza MS; Mahumud RA; Alam K; Gow J; Mollah MNH
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016137
[TBL] [Abstract][Full Text] [Related]
9. Construction and Validation of a UPR-Associated Gene Prognostic Model for Head and Neck Squamous Cell Carcinoma.
Wang T; Chen L; Xie F; Lin S; Lin Y; Chen J; Liu H; Wu Y
Biomed Res Int; 2022; 2022():8677309. PubMed ID: 35707371
[TBL] [Abstract][Full Text] [Related]
10. Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis.
Mosharaf MP; Reza MS; Gov E; Mahumud RA; Mollah MNH
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632527
[TBL] [Abstract][Full Text] [Related]
11. Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.
Alam MS; Sultana A; Reza MS; Amanullah M; Kabir SR; Mollah MNH
PLoS One; 2022; 17(5):e0268967. PubMed ID: 35617355
[TBL] [Abstract][Full Text] [Related]
12. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
[TBL] [Abstract][Full Text] [Related]
13. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
[TBL] [Abstract][Full Text] [Related]
14. Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View.
Korfiati A; Grafanaki K; Kyriakopoulos GC; Skeparnias I; Georgiou S; Sakellaropoulos G; Stathopoulos C
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163222
[TBL] [Abstract][Full Text] [Related]
15. Integrative Multi-Omics Analysis Reveals Candidate Biomarkers for Oral Squamous Cell Carcinoma.
Wan Z; Xiong H; Tan X; Su T; Xia K; Wang D
Front Oncol; 2021; 11():794146. PubMed ID: 35096593
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Novel Signature Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma.
Zheng H; Liu H; Lu Y; Li H
Front Surg; 2021; 8():717084. PubMed ID: 34631779
[No Abstract] [Full Text] [Related]
17. Interaction between DNMT3B and MYH11 via hypermethylation regulates gastric cancer progression.
Wang J; Xu P; Hao Y; Yu T; Liu L; Song Y; Li Y
BMC Cancer; 2021 Aug; 21(1):914. PubMed ID: 34380460
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1252-5p, regulated by Myb, inhibits invasion and epithelial-mesenchymal transition of pancreatic cancer cells by targeting NEDD9.
Xue Y; Wu T; Sheng Y; Zhong Y; Hu B; Bao C
Aging (Albany NY); 2021 Jul; 13(14):18924-18945. PubMed ID: 34314382
[TBL] [Abstract][Full Text] [Related]
19. Targeting the tumor stroma: integrative analysis reveal GATA2 and TORYAIP1 as novel prognostic targets in breast and ovarian cancer.
Erceylan ÖF; Savaş A; Göv E
Turk J Biol; 2021; 45(2):127-137. PubMed ID: 33907495
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma.
Qiang W; Dai Y; Xing X; Sun X
Comput Struct Biotechnol J; 2021; 19():1263-1276. PubMed ID: 33717423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
